Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC
Clinical trial NCT05888402 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05888402
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-20
- Primary completion
- 2024-10-08
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.